Physician Profile

Robin L. Travers, MD

Unclaimed Profile

About Dr. Travers

Robin L. Travers, MD is a healthcare provider in Chestnut Hill, MA specializing in dermatology. Robin trained at Boston University School of Medicine, graduating in 1993. According to Medicare claims data, Robin cared for 3,976 Medicare patients across 5,684 services.

Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.

Education & Training

Specialty

DERMATOLOGY (Primary)

Credentials & Licensing

MA license154067
NPI1578532388
NPI issued03/15/2006

Source: NPPES NPI Registry

Common questions

What kind of doctor is Dr. Travers?

Dr. Travers is a dermatology in Chestnut Hill, MA. This is the primary taxonomy recorded against the NPI in the federal registry, listed there as “DERMATOLOGY”.

NPI registry

What is Dr. Travers's address?

Dr. Travers is listed at 1244 BOYLSTON ST SUITE 302, Chestnut Hill, MA 02467. Addresses come from the NPI registry and can lag a move, so confirm before travelling.

NPI registry

How can I make an appointment with Dr. Travers?

The number on file is (617) 731-1600. Guide.md cannot book appointments or pass on messages — please call the office directly.

NPI registry

What is Dr. Travers's NPI number?

Dr. Travers's National Provider Identifier is 1578532388. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.

NPI registry

Where did Dr. Travers train?

Dr. Travers attended Boston University School of Medicine, graduating in 1993. This comes from the CMS National Downloadable File.

CMS public data

How long has Dr. Travers been practicing?

Dr. Travers has 33 years experience. Calculated from a graduation year of 1993, reported in the CMS National Downloadable File.

CMS public data

What procedures does Dr. Travers perform?

According to Medicare billing data, Dr. Travers performs procedures including destruction of precancer skin growth, 2-14 growths, destruction of skin growth, 1-14 growths and destruction of precancer skin growth, 1 growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.

Medicare claims

Has Dr. Travers confirmed this information?

Not yet. This profile is built from public federal data and has not been confirmed by Dr. Travers. If this is you, claiming it is free.

Guide.md

Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.